Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Sunday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

RVP stock opened at $0.68 on Friday. Retractable Technologies has a one year low of $0.56 and a one year high of $1.34. The firm has a 50-day simple moving average of $0.66 and a two-hundred day simple moving average of $0.87. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The firm has a market cap of $20.45 million, a price-to-earnings ratio of -1.26 and a beta of 1.98.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.